Jessica Read
Liverpool School of Tropical Medicine(GB)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Pharmacogenetics and Drug Metabolism, Colorectal Cancer Treatments and Studies, Thyroid Cancer Diagnosis and Treatment
Most-Cited Works
- → Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial(2011)1,527 cited
- → Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial(2011)289 cited
- → Vandetanib plus pemetrexed versus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancer (NSCLC): A randomized, double-blind phase III trial (ZEAL)(2009)88 cited
- → Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine(2014)61 cited
- → Vandetanib (VAN) in locally advanced or metastatic medullary thyroid cancer (MTC): A randomized, double-blind phase III trial (ZETA).(2010)61 cited
- → A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies(2015)58 cited
- → Pharmacokinetic Drug Interactions with Vandetanib during Coadministration with Rifampicin or Itraconazole(2011)49 cited
- → Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment(2010)31 cited
- → Optimization of an Enzymatic Antibody–Drug Conjugation Approach Based on Coenzyme A Analogs(2017)19 cited
- → Immunoprecipitation Middle-Up LC–MS for In Vivo Drug-To-Antibody Ratio Determination for Antibody–Drug Conjugates(2017)15 cited